Synchrony Financial SYF reported first-quarter 2024 adjusted earnings per share (EPS) of $1.18, which missed the Zacks Consensus Estimate by 13.9%. The bottom line declined 12.6% year over year. Net interest income improved 8.9% year over year to $4.4 billion, however, missing the consensus mark by 0.9%. The quarterly results suffered from lower net interest margins, new accounts and higher net-charge off rates and expenses. Nevertheless, SYF’s performance received an impetus from robust purchase volume stemming from the solid contributions from four of its five sales platforms. An expanding loan receivables portfolio also contributed to the upside. Synchrony Financial Price, Consensus and EPS Surprise Synchrony Financial Price, Consensus and EPS Surprise Synchrony Financial price-consensus-eps-surprise-chart | Synchrony Financial Quote Q1 Results in Detail Other income of Synchrony amounted to $1.2 billion, which surged by a huge margin year over year in the first quarter primarily due to gain on the sale of Pets Best. The metric also rose due to improved growth in interchange and protection product revenues of 3.9% and 22.6%, respectively. Total loan receivables of SYF grew 11.6% year over year to $101.7 billion and surpassed our estimate of $100.2 billion in the quarter under review. Total deposits were $83.6 billion, which rose 12.3% year over year. Provision for credit losses increased 46% year over year to $1.9 billion due to increased net charge-offs. The purchase volume of Synchrony advanced 2% year over year to $42.4 million in the first quarter. However, the figure lagged our estimate by 4.3%. Interest and fees on loans of $5.3 million improved 15% year over year, on the back of a growing average loan receivables portfolio, increased benchmark rates and lower payment rates. However, it missed our estimate by a small margin. Net interest margin deteriorated 67 basis points (bps) year over year to 14.55%. New accounts of 4.8 million slipped 8% year over year. Average active accounts increased 3% year over year to 71.7 million in the first quarter. Total other expenses of SYF amounted to $1.2 billion, up 7.8% year over year and surpassing our estimate by 3.8%. The efficiency ratio of 25.1% deteriorated 990 bps year over year in the quarter under review. Individual Sales Platforms' Update Home & Auto period-end loan receivables climbed 10% year over year to $32.6 billion on the back of lower payment rates. However, the purchase volume of $10.5 billion declined 3.2% year over year in the first quarter. Interest and fees on loans grew 12.8% year over year to $1.4 billion, missing our estimate by a small margin, on the back of growth in loan receivables and increased benchmark rates. Digital period-end loan receivables of $27.7 billion rose 11.2% year over year in the quarter under review on lower payment rates and higher purchase volume. Purchase volume was $12.6 billion, up 3% year over year on the back of growing average active accounts and better customer engagement. Interest and fees on loans climbed 15% year over year to $1.6 billion, missing our estimate by 3.2%, driven by growth in loan receivables, higher benchmark rates, maturing newer programs and lower payment rates. Diversified & Value period-end loan receivables grew 11.2% year over year to $19.6 billion in the first quarter on higher purchase volume and decreased payment rates. Purchase volume of $14 billion improved 4.3% year over year, attributable to solid in and out of partner spending. Interest and fees on loans advanced 13.5% year over year to $1.2 billion, beating our estimate by 2.2% on higher loan receivables and benchmark rates. Health & Wellness period-end loan receivables of $15.1 billion rose 19.7% year over year in the quarter under review on increased promotional purchase volume and reduction in payment rates. Purchase volume climbed 7.9% year over year to $4 billion on the back of strong active accounts growth, mainly in Dental, Pet and Cosmetic. Interest and fees on loans improved 18.2% year over year to $869 million, which outpaced our estimate of $825 million on higher volume and loan receivables. Lifestyle period-end loan receivables advanced 10.6% year over year to $6.6 billion in the first quarter on growing purchase volume and reduced payment rates. Purchase volume of $1.2 billion declined 4.5% year over year, due to lower transaction values. Interest and fees on loans climbed 14% year over year to $255 million, which lagged our estimate by 12.8%. Financial Position (as of Mar 31, 2024) Synchrony exited the first quarter with cash and equivalents of $20 billion, which increased from $14.3 billion at 2023-end. Total assets rose to $121.2 billion in the first quarter from $117.5 billion at 2023-end. Total borrowings advanced to $16.1 billion from $16 billion at the end of 2023. Total equity of $15.3 billion increased from $13.9 billion at the end of 2023. SYF’s balance sheet was consistently strong in the reported quarter, with total liquidity of $24.9 billion accounting for 20.5% of its total assets. Return on assets of 4.4% improved 210 bps year over year in the first quarter, and return on equity improved 1,740 bps year over year to 35.6% in the same time frame. Capital Deployment Synchrony returned capital worth $300 million through share buybacks and paid common stock dividends of $102 million in the first quarter of 2024. The company’s board approved a new share repurchase plan to buy shares worth $1 billion through Jun 30, 2025. It had a leftover share buyback capacity of $1.3 billion. 2024 Guidance The company earlier expected loan receivables growth to be around 6-8% for 2024. In 2023, loan receivables registered 11% year-over-year growth. The company anticipates payment rate moderation to continue but stay above the pre-pandemic levels. Net interest income was anticipated to be around $17.5-18.5 billion, indicating an improvement from the previous year’s figure of $17 billion. Net charge-offs were projected to be around 5.75-6%, which indicates an increase from the 2023 reported figure of 4.87%. The company expects net charge-offs to be at the highest during the first half and then reach pre-pandemic levels for the remainder of 2024. Management expects RSA/Average Loan Receivables to range between 3.5% and 3.75% in 2024, reflecting normalization in credit, high interest expense and portfolio mix being offset by improved purchase volume. Management expects an efficiency ratio in the range of 32.5-33.5% for 2024. Zacks Rank & Upcoming Releases Synchrony currently has a Zacks Rank #3 (Hold). Here are a few companies from the broader Finance space that are set to report their respective quarterly earnings soon. CleanSpark, Inc. CLSK has an Earnings ESP of +63.64% and a Zacks Rank #2 (Buy), at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. The Zacks Consensus Estimate for CLSK’s first-quarter 2024 earnings is pinned at 6 cents per share, implying a 126.1% surge from the year-ago quarter’s reported figure. CleanSpark’s earnings beat estimates in each of the trailing four quarters, the average surprise being 55.9%. Mr. Cooper Group Inc. COOP currently has an Earnings ESP of +1.90% and a Zacks Rank of 3. The Zacks Consensus Estimate for COOP’s first-quarter 2024 earnings is pegged at $2.11 per share, suggesting an 80.3% rise from the year-ago quarter’s reported number. Mr. Cooper Group’s earnings beat estimates in each of the trailing four quarters, the average surprise being 31.9%. Aflac Incorporated AFL currently has an Earnings ESP of +0.63% and a Zacks Rank of 3. The Zacks Consensus Estimate for AFL’s first-quarter 2024 earnings is pegged at $1.58 per share, suggesting a 1.9% rise from the year-ago quarter’s reported number. Aflac earnings beat estimates in three of the trailing four quarters, missing once, the average surprise being 9.1%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Aflac Incorporated (AFL):Free Stock Analysis Report Synchrony Financial (SYF):Free Stock Analysis Report MR. COOPER GROUP INC (COOP):Free Stock Analysis Report Cleanspark, Inc. (CLSK):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Synchrony (SYF) Q1 Earnings Miss on Low Net Interest Margin
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...